Interpretable machine learning model using peripheral blood for non‐invasive detection of moderate‐to‐severe myelofibrosis in JAK2 V617F ‐positive MPNs : A multicentre pilot proof‐of‐concept study

Documenti analoghi

• Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis
  di: Rithin Nedumannil, et al.
  Pubblicazione: (2025)
• RUNX1::CBFA2T2 rearranged acute myeloid leukemia transformed from JAK2 V617F mutated primary myelofibrosis
  di: Lina Han, et al.
  Pubblicazione: (2024)
• When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
  di: Jennifer O'Sullivan, et al.
  Pubblicazione: (2024)
• New drugs in myelofibrosis: Critical assessment of additional value to monotherapy with JAK inhibitors
  di: Naseema Gangat, et al.
  Pubblicazione: (2024)
• JAK inhibitor treatment‐resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?
  di: Maria Chiara Finazzi, et al.
  Pubblicazione: (2024)